Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Generalizability of FIGARO‐DKD...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Generalizability of FIGARO‐DKD and FIDELIO‐DKD Trial Criteria to the US Population Eligible for Finerenone

Generalizability of FIGARO‐DKD and FIDELIO‐DKD Trial Criteria to the US Population Eligible for Finerenone

Bibliographic Details
Main Authors: Nicholas Chiu, Rahul Aggarwal, George L. Bakris, Bertram Pitt, Deepak L. Bhatt
Format: Article
Language:English
Published: Wiley 2022-04-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
albuminuria
CKD
diabetes
finerenone
generalizability
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.025079
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.121.025079

Similar Items

  • Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials
    by: John M. Flack, et al.
    Published: (2023-12-01)
  • Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes: The FIDELIO-DKD Subgroup from China
    by: Haitao Zhang, et al.
    Published: (2023-08-01)
  • POS-829 Incidence and predictors of hyperkalaemia in patients with CKD and T2D in the FIDELIO-DKD trial
    by: R. Agarwal, et al.
    Published: (2021-04-01)
  • Effectiveness and safety of finerenone in diabetic kidney disease patients: a real-world observational study from China
    by: Jingying Zhou, et al.
    Published: (2024-12-01)
  • Finerenone in the management of diabetes kidney disease
    by: Parijat De, et al.
    Published: (2025-02-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs